Tom Harris
Appearances
- DateMay 20, 2024BACKGROUND: Proton pump inhibitors (PPIs) are the mainstay of therapy for non-erosive reflux disease (NERD). Potassium-competitive acid blockers (PCABs) have more potent and rapid inhibition of gastric acid secretion than PPIs…
Presenter
Yale School of MedicineSpeakers
University of California San DiegoWeill Cornell Medical CenterCase Western Reserve University
